The role of B and T lymphocytes in the pathogenesis of myelodysplastic syndromes (MDS)

被引：0

作者：

Borok, RZ ^{[1
]}

Dar, S ^{[1
]}

Shetty, V ^{[1
]}

Mundle, S ^{[1
]}

Allampallam, K ^{[1
]}

Alvi, S ^{[1
]}

Mazzoran, L ^{[1
]}

Zorat, F ^{[1
]}

Muzzamil, M ^{[1
]}

Mansoob, F ^{[1
]}

Shaher, A ^{[1
]}

Raza, A ^{[1
]}

机构：

[1] Rush Presbyterian St Lukes Med Ctr, Rush Canc Inst, Chicago, IL 60612 USA

来源：

BLOOD | 1999年 / 94卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3378

引用

页码：51B / 51B

页数：1

共 50 条

[21] The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes [J].

Sallman, David A. ;

List, Alan .

BLOOD, 2019, 133 (10) :1039-1048

[22] Role of DNA Methylation in the Pathogenesis and Treatment of Myelodysplastic Syndromes [J].

Khan, Hina ;

Vale, Cristina ;

Bhagat, Tushar ;

Verma, Amit .

SEMINARS IN HEMATOLOGY, 2013, 50 (01) :16-37

[23] The role of Chlamydia trachomatis infection in the pathogenesis of myelodysplastic syndromes [J].

Saralidze, T ;

Sheklashvili, M ;

Lolashvili, N ;

Mokhevishvili, L ;

Shvelidze, T .

EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) :87-87

[24] The role of CD40 in the pathogenesis of myelodysplastic syndromes [J].

Meers, S. ;

Kasran, A. ;

Boon, L. ;

Van Duppeni, V. ;

Boogaerts, M. ;

Verhoef, G. ;

Delforge, M. .

ACTA CLINICA BELGICA, 2006, 61 (02) :109-109

[25] ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES [J].

Brunetti, C. ;

Minervini, C. F. ;

Orsini, P. ;

Anelli, L. ;

Zagaria, A. ;

Coccaro, N. ;

Tota, G. ;

Minervini, A. ;

Casieri, P. ;

Cellamare, A. ;

Cumbo, C. ;

Impera, L. ;

Ricco, A. ;

Specchia, G. ;

Albano, F. .

LEUKEMIA RESEARCH, 2015, 39 :S69-S70

[26] CLASSIFICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) [J].

CATOVSKY, D .

MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 :3-3

[27] Iron overload in myelodysplastic syndromes (MDS) [J].

Norbert Gattermann .

International Journal of Hematology, 2018, 107 :55-63

[28] RISK ASSESSMENT IN MYELODYSPLASTIC SYNDROMES (MDS) [J].

Improta, S. ;

Gagliardi, A. ;

Lucania, A. ;

Della Cioppa, P. ;

Villa, M. R. ;

Esposito, M. ;

Quirino, A. ;

Mastrullo, L. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 :556-557

[29] Cyclosporin A in the treatment of myelodysplastic syndromes (MDS) [J].

Shirin, AD ;

Volkova, MA .

EUROPEAN JOURNAL OF CANCER, 1997, 33 :416-416

[30] BMT in children with myelodysplastic syndromes (MDS). [J].

Kardos, G ;

Vossen, JMJJ ;

Hoogerbrugge, PM .

BLOOD, 1997, 90 (10) :373-373

← 1 2 3 4 5 →